V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280009887 | 280008602 | 0 | 54 | Neo-adjuvant (N) | 2015-07-03 | 2015-07-20 | STS Rhabdo VIT0910 Vinc Irino Temoz | N | null | 280025130 | NOT MATCHED |
| 280009888 | 280011227 | 1.6 | 66.4 | Neo-adjuvant (N) | null | 2016-03-04 | Docetaxel + Gemcitabine (prior RT) | N | null | 280025130 | DOCETAXEL + GEMCITABINE |
| 280009889 | 280010357 | 1.65 | 63 | Palliative (P) | 2015-11-26 | 2015-12-17 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 280025143 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009890 | 280004917 | 1.88 | 71 | Palliative (P) | 2015-11-24 | 2015-11-27 | DOCETAXEL + GEMCITABINE | 02 | N | 280025153 | DOCETAXEL + GEMCITABINE |
| 280009891 | 280004917 | 0 | 90.1 | Curative (C) | 2013-05-31 | 2014-07-15 | EW EuroEwing 2012 Arm B VC | Y | N | 280025153 | NOT MATCHED |
| 280009892 | 280004923 | 1.76 | 18 | Palliative (P) | 2014-12-11 | 2015-09-23 | Docetaxel + Gemcitabine with GCSF | 01 | N | 280025168 | DOCETAXEL + GEMCITABINE |
| 280009893 | 280004927 | 1.66 | 78.1 | Palliative (P) | 2015-08-28 | 2015-09-03 | Carboplatin AUC 2 - 5 | N | Y | 280025171 | CARBOPLATIN |
| 280009894 | 280004931 | 1.76 | 72.8 | Curative (C) | 2017-10-01 | 2017-10-21 | Carboplatin AUC 6 - 10 | N | N | 280025177 | CARBOPLATIN |
| 280009895 | 280004931 | 1.79 | 98.7 | Neo-adjuvant (N) | 2017-11-10 | 2017-11-19 | Docetaxel+Gemcitabine (no prior RT) | Y | null | 280025177 | DOCETAXEL + GEMCITABINE |
| 280009896 | 280004934 | 1.6 | null | Palliative (P) | 2016-12-07 | 2016-12-19 | Docetaxel + Gemcitabine with GCSF | N | N | 280025182 | DOCETAXEL + GEMCITABINE |
| 280009897 | 280010361 | null | 55.6 | Curative (C) | 2013-12-28 | 2014-01-12 | EW Rel rEECur Topotecan/Cyclophosphamide | 01 | N | 280025184 | NOT MATCHED |
| 280009898 | 280008612 | 1.86 | 69.8 | null | null | 2013-08-23 | Carboplatin AUC 6 - 10 | N | Y | 280025184 | CARBOPLATIN |
| 280009899 | 280004942 | 1.65 | 68 | Curative (C) | 2014-03-06 | 2014-03-13 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025200 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009900 | 280008616 | null | 91.1 | Neo-adjuvant (N) | 2015-06-18 | 2015-08-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025201 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009901 | 280004947 | 0 | null | Not known (9) | 2016-10-09 | 2018-05-21 | null | N | N | 280025204 | NOT MATCHED |
| 280009902 | 280004949 | 1.64 | 10.8 | Curative (C) | null | 2017-04-08 | Cetuximab 7 day (>Cycle 2) | N | null | 280025207 | CETUXIMAB |
| 280009903 | 280004949 | 1.66 | 81.2 | null | 2014-10-13 | 2014-10-13 | Cetuximab 7 day (>Cycle 2) | N | N | 280025207 | CETUXIMAB |
| 280009904 | 280004951 | 1.75 | null | Adjuvant (A) | 2014-05-22 | 2014-05-28 | NB Rel CCLG guidelines Irin & Temoz | 02 | Y | 280025212 | NOT MATCHED |
| 280009905 | 280004952 | null | 74.6 | Disease modification (D) | 2017-12-06 | 2017-12-25 | STS Rhabdo VIT0910 Vinc Irino Temoz | N | null | 280025219 | NOT MATCHED |
| 280009906 | 280008622 | 1.65 | 56.8 | Palliative (P) | 2015-09-12 | 2015-09-19 | Cetuximab 7 day (>Cycle 2) | N | Y | 280025237 | CETUXIMAB |
| 280009907 | 280004958 | 1.8 | 73.9 | Palliative (P) | 2016-09-23 | 2016-09-23 | Docetaxel+Gemcitabine (no prior RT) | 01 | N | 280025238 | DOCETAXEL + GEMCITABINE |
| 280009908 | 280010368 | 1.77 | 76.9 | Curative (C) | 2016-03-02 | 2016-04-02 | Cetuximab 7 day (>Cycle 2) | Y | Y | 280025240 | CETUXIMAB |
| 280009909 | 280008624 | null | 62.3 | Curative (C) | 2017-08-13 | 2017-09-03 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025243 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009910 | 280010370 | 1.58 | 76 | Neo-adjuvant (N) | 2016-08-19 | 2016-08-22 | Carboplatin AUC 6 - 10 | 2 | N | 280025253 | CARBOPLATIN |
| 280009911 | 280004962 | 1.76 | null | Curative (C) | 2013-06-01 | 2013-09-13 | Carboplatin AUC 6 - 10 | N | N | 280025260 | CARBOPLATIN |
| 280009912 | 280004966 | 1.58 | 67 | Disease modification (D) | 2014-03-26 | 2014-03-29 | CETUXIMAB | N | null | 280025261 | CETUXIMAB |
| 280009913 | 280004967 | null | 83.1 | Curative (C) | 2017-03-01 | 2017-04-30 | Carboplatin AUC 6 - 10 | N | N | 280025266 | CARBOPLATIN |
| 280009914 | 280004968 | 1.87 | 90.9 | null | null | 2014-02-01 | Cetuximab 7 day (>Cycle 2) | 2 | null | 280025267 | CETUXIMAB |
| 280009915 | 280004969 | null | null | Palliative (P) | 2016-09-22 | 2016-10-15 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 280025271 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009916 | 280008632 | 1.6 | 66.3 | Palliative (P) | 2017-09-16 | 2017-09-16 | Docetaxel + Gemcitabine with GCSF | 02 | N | 280025273 | DOCETAXEL + GEMCITABINE |
| 280009917 | 280004972 | null | 73.5 | null | 2016-09-16 | 2016-10-11 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 280025277 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009918 | 280004977 | null | 82 | Curative (C) | null | 2016-08-21 | CETUXIMAB | 2 | N | 280025284 | CETUXIMAB |
| 280009919 | 280004978 | null | 112 | Curative (C) | 2013-10-07 | 2013-10-18 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025284 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009920 | 280012002 | 1.65 | 59.6 | Palliative (P) | 2014-12-18 | 2015-02-28 | Docetaxel + Gemcitabine (prior RT) | null | null | 280025289 | DOCETAXEL + GEMCITABINE |
| 280009921 | 280004979 | 0 | 10.7 | Neo-adjuvant (N) | 2015-06-12 | 2016-05-18 | NB HRNBL-1 COJEC Ind COURSE B | null | null | 280025292 | NOT MATCHED |
| 280009922 | 280004981 | 0 | 74.5 | Neo-adjuvant (N) | 2015-06-10 | 2015-11-28 | EW EuroEwing 2012 Arm A VAC | 02 | N | 280025293 | NOT MATCHED |
| 280009923 | 280010377 | 1.65 | 82 | Palliative (P) | null | 2017-02-05 | Cetuximab 7 day (>Cycle 2) | N | null | 280025300 | CETUXIMAB |
| 280009924 | 280004983 | null | 95.7 | Palliative (P) | 2015-08-01 | 2015-08-28 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025300 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009925 | 280004983 | 0 | null | Neo-adjuvant (N) | 2017-11-20 | 2017-11-26 | Carboplatin AUC 2 - 5 | 02 | N | 280025300 | CARBOPLATIN |
| 280009926 | 280004983 | 1.67 | 60.9 | null | 2018-03-17 | 2018-04-07 | CETUXIMAB | Y | N | 280025300 | CETUXIMAB |
| 280009927 | 280004984 | 1.76 | 75.7 | Palliative (P) | 2018-09-25 | 2018-10-05 | Docetaxel + Gemcitabine with GCSF | 02 | N | 280025323 | DOCETAXEL + GEMCITABINE |
| 280009928 | 280004985 | 0 | 52.1 | Curative (C) | 2017-09-15 | 2017-09-25 | EW EuroEwing 2012 Arm A VAC | Y | Y | 280025324 | NOT MATCHED |
| 280009929 | 280004987 | null | null | Palliative (P) | 2015-07-20 | 2015-09-27 | Carboplatin AUC 2 - 5 | null | null | 280025326 | CARBOPLATIN |
| 280009930 | 280008639 | null | 61 | Palliative (P) | 2013-09-04 | 2013-11-06 | Carboplatin AUC 6 - 10 | N | null | 280025327 | CARBOPLATIN |
| 280009931 | 280004989 | 1.81 | 93.1 | Palliative (P) | 2017-09-03 | 2017-09-03 | Carboplatin AUC 2 - 5 | N | N | 280025331 | CARBOPLATIN |
| 280009932 | 280004989 | 1.73 | 43.8 | Curative (C) | 2014-03-12 | 2014-04-19 | Carboplatin AUC 6 - 10 | N | Y | 280025331 | CARBOPLATIN |
| 280009933 | 280004989 | 1.8 | null | Curative (C) | 2016-04-20 | 2016-04-27 | Carboplatin AUC 6 - 10 | 02 | N | 280025331 | CARBOPLATIN |
| 280009934 | 280008641 | null | 83.3 | Curative (C) | null | 2013-05-08 | STS Rhabdomyosarco RMS 2005 IVADoVV | null | null | 280025354 | NOT MATCHED |
| 280009935 | 280010383 | 1.7 | 72.6 | Neo-adjuvant (N) | null | 2014-06-08 | Docetaxel + Gemcitabine (prior RT) | N | N | 280025357 | DOCETAXEL + GEMCITABINE |
| 280009936 | 280004993 | 1.86 | 88.6 | Palliative (P) | 2013-10-22 | 2014-05-27 | Docetaxel + Gemcitabine with GCSF | N | N | 280025357 | DOCETAXEL + GEMCITABINE |